Case management of the anemic patient: epoetin alfa--focus on osteitis fibrosa.

Research output: Contribution to journalArticle

Abstract

Most patients with anemia caused by end-stage renal disease respond well to Epoetin alfa therapy, but in a small number the hematocrit fails to rise as expected. A potential cause of suboptimal response is osteitis fibrosa. Understanding the pathophysiology, manifestations, diagnosis, and treatment for osteitis fibrosa helps nurses to identify this condition as a cause of resistance to Epoetin alfa and to manage patients appropriately.

Original languageEnglish (US)
Pages (from-to)604-607
Number of pages4
JournalANNA journal / American Nephrology Nurses" Association
Volume20
Issue number5
StatePublished - Oct 1 1993
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Case management of the anemic patient: epoetin alfa--focus on osteitis fibrosa.'. Together they form a unique fingerprint.

Cite this